These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3622945)

  • 41. Extracellular mucus and repair of superficial mucosal injury by restitution.
    Wallace JL
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():27-33. PubMed ID: 2725122
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colloidal bismuth subcitrate in peptic ulcer--a review.
    Tytgat GN
    Digestion; 1987; 37 Suppl 2():31-41. PubMed ID: 3305117
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Evaluation of results of surgical treatment of peptic ulcer associated with Helicobacter pylori].
    Lokhvitskiĭ SV; Darvin VV; Proshin AV; Bashirova ES; Butorov IL
    Vestn Khir Im I I Grek; 1998; 157(2):18-20. PubMed ID: 9691374
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mucus and pepsin role in gastric damage prevention by H2-receptor antagonists and antiulcer drugs.
    Impicciatore M; Morini G; Chiavarini M; Plazzi PV; Agosti A; Soldani G
    Acta Physiol Hung; 1984; 64(3-4):253-7. PubMed ID: 6152367
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is gastro-intestinal mucus an ion-selective barrier?
    Guth D; von Engelhardt W
    Symp Soc Exp Biol; 1989; 43():117-21. PubMed ID: 2641406
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat.
    Koo J; Ho J; Lam SK; Wong J; Ong GB
    Gastroenterology; 1982 May; 82(5 Pt 1):864-70. PubMed ID: 7060908
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Present and future treatment of peptic ulcer and potential role of DE-NOL.
    Scand J Gastroenterol Suppl; 1982; 80():49-57. PubMed ID: 6761852
    [No Abstract]   [Full Text] [Related]  

  • 48. [Characteristics of the effects of de-nol on the course of erosive-ulcerative lesions of the esophagus, stomach and duodenum associated with Helicobacter pylori].
    Grebenev AL; Miagkova LP; Golochevskaia VS; Lapina TL; Sklianskaia OA
    Klin Med (Mosk); 1995; 73(2):34-7. PubMed ID: 7609414
    [No Abstract]   [Full Text] [Related]  

  • 49. [On functional-morphological changes in peptic ulcer].
    Atakhanov EI
    Ter Arkh; 1967 Jun; 39(6):10-5. PubMed ID: 5600676
    [No Abstract]   [Full Text] [Related]  

  • 50. Gastric mucosal protective mechanisms: roles of epithelial bicarbonate and mucus secretions.
    Garner A; Flemström G; Allen A; Heylings JR; McQueen S
    Scand J Gastroenterol Suppl; 1984; 101():79-86. PubMed ID: 6100627
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The ultrastructural localisation of De-Nol (colloidal tripotassium dicitrato-bismuthate--TDB) in the upper gastrointestinal tract of man and rodents following oral and instrumental administration.
    Coghill SB; Hopwood D; McPherson S; Hislop S
    J Pathol; 1983 Feb; 139(2):105-14. PubMed ID: 6827397
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gastric mucus and bicarbonate secretion in relation to mucosal protection.
    Kauffman GL
    J Clin Gastroenterol; 1981; 3(Suppl 2):45-50. PubMed ID: 7320468
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Efficacy of colloid bismuth subcitrate (De-Nol) in gastropathies induced by nonsteroid anti-inflammatory drugs: an open controlled 4-week trial].
    Karateev AE; Nasonov EL; Radenska-Lopovok SG
    Ter Arkh; 2005; 77(2):46-9. PubMed ID: 15807452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate.
    Miller JP; Hollanders D; Ravenscroft MM; Tweedle DE; Martin DF
    Scand J Gastroenterol Suppl; 1982; 80():39-42. PubMed ID: 6761851
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"].
    Gorshkov VA
    Klin Med (Mosk); 2002; 80(9):66-70. PubMed ID: 12416232
    [No Abstract]   [Full Text] [Related]  

  • 56. Healing-promoting action of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea with dual action on chronic gastric and duodenal ulcers induced by acetic acid in rats.
    Sekiguchi H; Hamada K; Aijima H; Taga F; Uchida H; Nishino K
    Arzneimittelforschung; 1993 Feb; 43(2):139-43. PubMed ID: 8096134
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Progress in the treatment of acute gastroduodenal mucosal lesions (AGML).
    Speranza V; Basso N
    World J Surg; 1977 Jan; 1(1):35-44. PubMed ID: 17230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Physiopathology of the gastro-duodenal ulcer: role of the mucus].
    de Graef J; Gerard A; Willems G; Bremen J; Ley R; Verbeustel S; Woussen-Colle MC
    Brux Med; 1970 Dec; 50(12):1075-86. PubMed ID: 5501937
    [No Abstract]   [Full Text] [Related]  

  • 59. [Colloidal bismuth subcitrate (de-nol) in the treatment of peptic ulcer].
    Grigo'rev PIa; Isakov VA; Iakovenko EP
    Klin Med (Mosk); 1989 May; 67(5):17-22. PubMed ID: 2671482
    [No Abstract]   [Full Text] [Related]  

  • 60. Dual effect of female sex steroids on drug-induced gastroduodenal ulcers in the rat.
    Drago F; Montoneri C; Varga C; Làszlò F
    Life Sci; 1999; 64(25):2341-50. PubMed ID: 10374897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.